Position in ABBV
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$16,160,069
+$3,119,804 QoQ
Shares Held
64,219
+7.1% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
2.13%
of 13F equity value
Holder Rank
#708
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ascent Wealth Partners, LLC holds $36,435,678 across 7 Drug Manufacturers - General names. ABBV ranks #1 (44.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
64,219 | $16,160,069 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
58,756 | $7,423,233 | |
| 3 | AMGN |
Amgen Inc
|
14,199 | $5,141,741 | |
| 4 | NVS |
Novartis AG
|
16,473 | $2,581,648 | |
| 5 | MRK |
Merck & Co., Inc.
|
17,254 | $2,217,139 | |
| 6 | PFE |
Pfizer Inc
|
89,916 | $2,165,177 | |
| 7 | JNJ |
Johnson & Johnson
|
2,940 | $746,671 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,160,069 | 64,219 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $13,040,265 | 59,958 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $13,364,837 | 58,492 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $13,777,787 | 59,505 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $11,186,203 | 60,264 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $13,194,312 | 62,974 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $10,633,923 | 59,842 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $11,702,862 | 59,261 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $10,266,329 | 59,855 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $10,973,892 | 60,263 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $9,318,191 | 60,129 | Shares | Sole | 2024-01-22 | |
| 2023-09-30 | $8,859,082 | 59,433 | Shares | Sole | 2023-10-20 | |
| 2023-06-30 | $8,092,826 | 60,067 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $8,680,883 | 54,470 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $8,672,154 | 53,661 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $7,328,805 | 54,607 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $8,915,137 | 58,208 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $9,631,765 | 59,415 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $7,706,426 | 56,916 | Shares | Sole | 2022-01-27 | |
| 2021-09-30 | $6,420,638 | 59,522 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $6,806,947 | 60,431 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $6,513,437 | 60,187 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $6,320,028 | 58,983 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $5,146,350 | 58,755 | Shares | Sole | 2020-10-22 | |
| 2020-06-30 | $5,659,193 | 57,641 | Shares | Sole | 2020-07-21 | |
| 2020-03-31 | $4,299,935 | 56,437 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||